FTE Funding. Momenta will provide [**] FTEs during the [**] period commencing October 1, 2003 under this Agreement and [**] FTEs during the following [**] period under this Agreement, devoted exclusively to efforts on behalf and in furtherance of the Collaborative Program. As compensation for the provision of such FTEs, BCWI shall pay Momenta, effective as of October 1, 2003, at the FTE Rate. Additional FTEs, as mutually agreed to in the applicable Annual Collaboration Plan, will be provided by Momenta, and paid for by BCWI (subject to the provisions of Section 4.11.8) at the FTE Rate ("ADDITIONAL FTE'S"). Within thirty (30) days after the end of each Quarter during such time periods, Momenta shall provide to BCWI a report of the number of FTEs actually devoted by Momenta to the Collaborative Program during such just-ended Quarter and payments will be due by BCWI within forty-five (45) days after receipt of such report, based on the number of FTEs actually committed by Momenta to the Collaborative Program during such Quarter at the FTE Rate, PRO RATA for such actual number of FTEs. Momenta shall track the number of FTEs devoted to the Collaborative Program on a monthly basis in accordance with Momenta's standard record-keeping practices (including without limitation the use of at a minimum monthly timesheets) (the "FTE RECORDS").
Appears in 2 contracts
Sources: Collaboration and License Agreement (Momenta Pharmaceuticals Inc), Collaboration and License Agreement (Momenta Pharmaceuticals Inc)
FTE Funding. Momenta will provide [**] FTEs during the [**] period commencing October 1, 2003 under this Agreement and [**] FTEs during the following [**] period under this Agreement, devoted exclusively to efforts on behalf and in furtherance of the Collaborative Program. As compensation for the provision of such FTEs, BCWI shall pay Momenta, effective as of October 1, 2003, at the FTE Rate. Additional FTEs, as mutually agreed to in the applicable Annual Collaboration Plan, will be provided by Momenta, and paid for by BCWI (subject to the provisions of Section 4.11.8) at the FTE Rate ("ADDITIONAL “Additional FTE'S"’s”). Within thirty (30) days after the end of each Quarter during such time periods, Momenta shall provide to BCWI a report of the number of FTEs actually devoted by Momenta to the Collaborative Program during such just-ended Quarter and payments will be due by BCWI within forty-five (45) days after receipt of such report, based on the number of FTEs actually committed by Momenta to the Collaborative Program during such Quarter at the FTE Rate, PRO RATA pro rata for such actual number of FTEs. Momenta shall track the number of FTEs devoted to the Collaborative Program on a monthly basis in accordance with Momenta's ’s standard record-keeping practices (including without limitation the use of at a minimum monthly timesheets) (the "“FTE RECORDS"Records”).
Appears in 1 contract
Sources: Collaboration and License Agreement (Momenta Pharmaceuticals Inc)